BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9369280)

  • 1. Calcium signaling mechanisms in renal vascular responses to vasopressin in genetic hypertension.
    Feng JJ; Arendshorst WJ
    Hypertension; 1997 Nov; 30(5):1223-31. PubMed ID: 9369280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium entry and mobilization signaling pathways in ANG II-induced renal vasoconstriction in vivo.
    Ruan X; Arendshorst WJ
    Am J Physiol; 1996 Mar; 270(3 Pt 2):F398-405. PubMed ID: 8780240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ; Arendshorst WJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-1 and vasopressin signalling in blood vessels of young SHR in comparison to adult SHR.
    Yang XP; Touyz RM; Nguyen PV; Deng LY; Li JS; Schiffrin EL
    Hypertens Res; 1996 Jun; 19(2):121-32. PubMed ID: 10968205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of V(1) receptors in renal resistance vessels of rats developing genetic hypertension.
    Vågnes O; Feng JJ; Iversen BM; Arendshorst WJ
    Am J Physiol Renal Physiol; 2000 Jun; 278(6):F940-8. PubMed ID: 10836981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal hemodynamics in young and old spontaneously hypertensive rats during intrarenal infusion of arginine vasopressin.
    Christiansen RE; Roald AB; Gjerstad C; Tenstad O; Iversen BM
    Kidney Blood Press Res; 2001; 24(3):176-84. PubMed ID: 11528210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variations in cell signaling pathways for different vasoconstrictor agonists in renal circulation of the rat.
    Bauer J; Parekh N
    Kidney Int; 2003 Jun; 63(6):2178-86. PubMed ID: 12753305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced response to AVP in the interlobular artery from the spontaneously hypertensive rat.
    Hansen FH; Vågnes ØB; Iversen BM
    Am J Physiol Renal Physiol; 2005 May; 288(5):F1023-31. PubMed ID: 15598845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats.
    Ruan X; Arendshorst WJ
    Am J Physiol; 1996 Jun; 270(6 Pt 2):F945-52. PubMed ID: 8764313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exaggerated Ca2+ signaling in preglomerular arteriolar smooth muscle cells of genetically hypertensive rats.
    Iversen BM; Arendshorst WJ
    Am J Physiol; 1999 Feb; 276(2):F260-70. PubMed ID: 9950957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pressor actions of arginine vasopressin in pithed Sprague-Dawley, Wistar-Kyoto and spontaneously hypertensive rats before and after treatment with nifedipine or pertussis toxin.
    Tabrizchi R; Triggle CR
    J Hypertens; 1991 Sep; 9(9):813-8. PubMed ID: 1663982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norepinephrine-induced calcium signaling pathways in afferent arterioles of genetically hypertensive rats.
    Salomonsson M; Arendshorst WJ
    Am J Physiol Renal Physiol; 2001 Aug; 281(2):F264-72. PubMed ID: 11457717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Ca2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states.
    Vagnes OB; Hansen FH; Feng JJ; Iversen BM; Arendshorst WJ
    Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1249-56. PubMed ID: 15657301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium recruitment in renal vasculature: NE effects on blood flow and cytosolic calcium concentration.
    Salomonsson M; Arendshorst WJ
    Am J Physiol; 1999 May; 276(5):F700-10. PubMed ID: 10330052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats.
    Chatziantoniou C; Daniels FH; Arendshorst WJ
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F372-82. PubMed ID: 2386211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats.
    Chatziantoniou C; Arendshorst WJ
    Am J Physiol; 1992 Oct; 263(4 Pt 2):F573-80. PubMed ID: 1329556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension.
    Chatziantoniou C; Ruan X; Arendshorst WJ
    Am J Physiol; 1993 Dec; 265(6 Pt 2):F845-52. PubMed ID: 7904421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of angiotensin in the renal vasoconstriction observed during the development of genetic hypertension.
    Arendshorst WJ; Chatziantoniou C; Daniels FH
    Kidney Int Suppl; 1990 Nov; 30():S92-6. PubMed ID: 2259085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ca2+ sensitization and Ca2+ entry in the control of blood pressure and adrenergic vasoconstriction in conscious Wistar-Kyoto and spontaneously hypertensive rats.
    Behuliak M; Pintérová M; Bencze M; Petrová M; Líšková S; Karen P; Kuneš J; Vaněčková I; Zicha J
    J Hypertens; 2013 Oct; 31(10):2025-35. PubMed ID: 24107733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular signaling and proliferative action of AVP in mesangium of SHR: effect of low density lipoprotein.
    Ishikawa S; Kusaka I; Higashiyama M; Nagasaka S; Saito T; Honda K; Saito T
    Kidney Int; 1996 Nov; 50(5):1506-14. PubMed ID: 8914016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.